ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,870.62
      -1.32%
      US Tech 100
      19,926.80
      0.32%
      Dow Jones
      43,444.99
      -0.70%
      Brent Oil
      71.555
      1.20%
      Bitcoin
      91,757.86
      2.10%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ABVC BioPharma Inc (ABVC)

      7. ABVC BioPharma Inc (ABVC) Financials

      ABVC BioPharma Inc

      ABVC BioPharma Inc (ABVC)

      NASDAQ
      0.500001
      -0.051
      (-9.26%)
      Closed November 15 4:00PM
      Delayed by 15 minutes
      0.500001
      0.00
      ( 0.00% )
      Pre Market: 4:55AM
      Delayed by 15 minutes

      ABVC BioPharma Inc Financial Summary

      The current ABVC market cap is 6.21M. The company's latest EPS is USD -0.8466 and P/E is -0.59.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 128k6k16k2k1,000
      Operating Income -1.91M-3.45M-902k-1.96M-3.44M
      Net Income -1.82M-3.52M-2.06M-3.11M-3.93M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 702k483k356k970k152k
      Operating Income -3.46M-8.51M-11.71M-15.11M-8.22M
      Net Income -3.64M-9.79M-12.84M-16.42M-10.52M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 10.74M9.32M16.59M14.49M14.46M
      Total Liabilities 9M9.69M7.53M6.36M6.97M
      Total Equity 1.74M-367k9.06M8.13M7.49M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 6.93M11.61M13.7M9.86M14.49M
      Total Liabilities 7.05M8.95M4.83M6.62M6.36M
      Total Equity -125k2.66M8.87M3.24M8.13M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -1.5M-2.4M-3.76M-4.24M-473k
      Investing N/A -441k-514k-360k N/A
      Financing 2.21M2.18M3.83M3.92M676k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -3.14M-4.56M-7.6M-7.4M-4.24M
      Investing -35k-225k-806k-1.72M-360k
      Financing 3.09M9.57M10M4.01M3.92M

      Stats and Ratios

      Market Cap 6.21M
      Price to Earnings Ratio -0.59
      Price to Sales Ratio 40.98
      Price to Cash Ratio 104.17
      Price to Book Ratio 0.76
      Dividend Yield -

      Share Statistics

      Shares Outstanding 12.42M
      Average Volume (1 week) 131.48k
      Average Volume (1 Month) 228.44k
      52 Week Change -67.95%
      52 Week High 2.45
      52 Week Low 0.4053
      Spread (Intraday) 0.08 (13.79%)

      Company Info

      Company Name ABVC BioPharma Inc
      Address 401 ryland st ste 200-a, reno
      reno, nevada 89502
      Website https://www.abvcpharma.com
      Industry pharmaceutical preparations (2834)